07:00 , Apr 15, 2013 |  BioCentury  |  Emerging Company Profile

Abcodia: Banking on biomarkers

Abcodia Ltd. is using blood samples that have been taken annually by the U.K. Collaborative Trial for Ovarian Cancer Screening to identify serum biomarkers that can detect breast, lung, pancreatic and colorectal tumors at least...
07:00 , Apr 30, 2012 |  BC Week In Review  |  Company News

Abcodia, Biouniversa deal

The companies partnered to develop Biouniversa's Biouniversa BCL2-associated athanogene 3 ( BAG3 ; CAIR-1 ) ELISA assay technology to detect pancreatic cancer in asymptomatic individuals and at the earliest stages. The partners will use Abcodia's...